| Silence Therapeutics Collaborates with MiReven to Evaluate Delivery of miR-7 Mimetic |
Abstract
|
|
Heather Cartwright |
|
| Sanofi Collaborates with Oncodesign to Develop Inhibitors of Challenging Kinase Targets |
Abstract
|
|
Heather Cartwright |
|
| SFJ Pharmaceuticals to Conduct Phase III Trial of Pfizer’s Dacomitinib in First-Line Advanced NSCLC |
Abstract
|
|
Heather Cartwright |
|
| Allergan Strengthens its Ophthalmology Pipeline with US$1.5 B Alliance with Molecular Partners |
Abstract
|
|
Heather Cartwright |
|
| Genmab Signs US$1.1 B Daratumumab Licence Agreement with Janssen Biotech |
Abstract
|
|
Heather Cartwright |
|
| Merck Serono Licenses Global Rights to Symphogen’s Sym004 Cancer Antibody Mixture |
Abstract
|
|
Heather Cartwright |
|
| Pfizer Out-Licenses Clinical-Stage Cancer Antibody to VLST |
Abstract
|
|
Heathe Cartwright |
|
| Baxter Expands its Oncology Pipeline by Licensing European Rights to Onconova Therapeutics’ Rigosertib |
Abstract
|
|
Heather Cartwright |
|
| Hospira Boosts Antibiotic Business with Acquisition of Orchid’s API Facilities |
Abstract
|
|
Heather Cartwright |
|
| Valeant to Lead US Dermatology Market with US$2.6 B Medicis Buyout |
Abstract
|
|
Heather Cartwright |
|
| Sunovion Strengthens its Respiratory Portfolio by Acquiring Elevation Pharmaceuticals |
Abstract
|
|
Heather Cartwright |
|
| Vascular Pharma Completes US$16 M Series A Financing and Grants Janssen Biotech Acquisition Option |
Abstract
|
|
Heather Cartwright |
|
| AstraZeneca Forms Joint Venture with Wuxi AppTec to Accelerate Biologics Development in China |
Abstract
|
|
Heather Cartwright |
|
| Pfizer Signs Long-Term Generics Collaboration with Mylan in Japan |
Abstract
|
|
Heather Cartwright |
|
